LRCX trades against a final fair-value range of $132.71-$237.30, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $133, high $237, with mid-point at $183.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$183
Margin of safety
-60.9%
Confidence
87/100
Moat
9/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$295.16Price
Low $132.71
Mid $183.48
High $237.3
LRCX trades against a final fair-value range of $132.71-$237.30, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Intangible Assets
Intangible Assets
Switching Costs
Switching Costs
Bull thesis
internal valuation cross-checks of $310.47 relies on ungrounded perpetual multiple expansion.
Our financial-history view of LRCX (LRCX) covers revenue, gross profit, operating income, and net income across the past five fiscal years, with year-over-year growth and margin context for each line.
The revenue trajectory is reported in the financial-history section with year-over-year growth rates. Direction and acceleration are summarised inline; the full table sits within the parent financials tab.
We track operating income alongside operating margin so the reader can separate top-line growth from operating leverage. The numbers analysis subsection flags one-offs, restructuring, and stock-based-compensation effects when material.
Net income is shown together with EPS so dilution and buybacks are visible alongside profit. Where reported net income diverges materially from operating cash flow, the discrepancy is called out in the numbers-analysis subsection.
FAQ
LRCX — frequently asked questions
Based on our latest analysis, LRCX looks meaningfully overvalued. The current price is $295 versus a composite fair-value midpoint of $183 (range $133–$237), which implies roughly 37.8% downside to the midpoint.
Our composite fair-value range for LRCX is $133–$237, with a midpoint of $183. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for LRCX's archetype.
Our current rating for LRCX is Sell with a confidence score of 87/100. LRCX is rated Sell at $295.16 versus the reconciled fair value midpoint of $183.48, implying -37.84% upside/downside. Confidence is separately disclosed at 87/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for LRCX are: Prolonged Memory Downturn; Severe Export Controls; Advanced Packaging Share Loss. The single biggest risk is Prolonged Memory Downturn: Extended reduction in NAND and DRAM capex significantly depresses equipment sales and margins beyond modeled downcycle parameters.
Our current rating for LRCX is Sell, issued with a confidence score of 87/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($133–$237) versus the current price of $295.
LRCX is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for LRCX.